PWMG
SNDX icon

Private Wealth Management Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Private Wealth Management Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-266
Closed -$3.27K – 1588
2025
Q1 		$3.27K Buy
266
+23
+9% +$324 ﹤0.01% 887
2024
Q4 		$3.21K Buy
+243
New +$4.16K ﹤0.01% 916

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Private Wealth Management Group's SNDX Position: Q2 2025 in Review

Private Wealth Management Group sold out of Syndax Pharmaceuticals (SNDX) in Q2 2025, closing a stake of 266 shares — an estimated $3.27K sold.

Private Wealth Management Group first reported a position in SNDX in Q4 2024 and held it in 2 quarters. The position peaked at $3.27K in Q1 2025. 216 funds tracked by Wall St. Rank hold SNDX as of Q2 2025.

  • Private Wealth Management Group reported no remaining Syndax Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Private Wealth Management Group sold 266 Syndax Pharmaceuticals shares in Q2 2025, an estimated $3.27K.
  • Private Wealth Management Group first reported a position in Syndax Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Private Wealth Management Group's Syndax Pharmaceuticals position peaked at $3.27K in Q1 2025.
  • 216 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2025.

Based on Private Wealth Management Group's 13F filing for Q2 2025, filed 29 Jul 2025.